BioXcel Therapeutics (BTAI) Reports Q2 Loss of $1.06/sh
BioXcel Therapeutics (NASDAQ: BTAI) reported Q2 EPS of ($1.06), versus ($0.54) reported last year.
For earnings history and earnings-related data on BioXcel Therapeutics (BTAI) click here.
BioXcel Therapeutics (NASDAQ: BTAI) reported Q2 EPS of ($1.06), versus ($0.54) reported last year.
For earnings history and earnings-related data on BioXcel Therapeutics (BTAI) click here.